Contact Information Available for logged-in reporters only Advances in molecular medicine, genetic testing, and laboratory technologies to be featured at the College of American Pathologists annual meeting CAP 14: Sept. 7-10, Chicago NORTHFIELD, ILL. New science in molecular and genetic testing for breast, colon, and prostate cancer, as well as leukemia, will be among the special features at the College of American Pathologists annual scientific and education meeting, CAP'14--THE Pathologists' Meeting, Sept. 7-10 at the Hyatt Regency in Chicago. More accurate diagnoses and precise treatments through molecular diagnostics offer new hope for the millions of patients battling cancer each year, said CAP President Gene N. Herbek, MD, FCAP. As the doctors who diagnose disease and guide treatment, pathologists want to keep current on the new diagnostic procedures that can enhance patient care. CAP14 brings together the leading experts in laboratory medicine to share the latest information to benefit patients. World-renowned experts in pathology and laboratory medicine will examine the clinical and economic impact of genomic-based testing, as well as share insights on the pathologists role in coordinated care models and appropriate test selection to reduce medical costs and unnecessary testing. Highlighted scientific topics and educational courses include: Special Scientific Plenary … Continue reading →

Contact Information Available for logged-in reporters only Physician Experts Available to Discuss Advances in Molecular Medicine and Genetic Testing at the College of American Pathologists annual meeting CAP 14: Sept. 7-10, Chicago NORTHFIELD, ILL. New science in molecular and genetic testing for breast, colon, and prostate cancer, as well as leukemia, will be among the special features at the College of American Pathologists annual scientific and education meeting, CAP14THE Pathologists Meeting, Sept. 7-10 at the Hyatt Regency in Chicago. World-renowned experts in pathology and laboratory medicine are available to speak about the clinical and economic impact of genomic-based testing, as well as share insights on the pathologists role in coordinated care models and appropriate test selection to reduce medical costs and unnecessary testing. Highlighted scientific topics and educational courses to be featured at CAP14 include: Special Scientific Plenary Session: Molecular MedicineCan We Afford It?, lead by national thought leaders: o Debra G.B. Leonard, MD, PhD, FCAP, chair of pathology at the University of Vermont o David O. Meltzer, MD, PhD, a health economist at the University of Chicago o Adam C. Berger, PhD, director of the Instituteof Medicines Roundtable on Translating Genomic-Based Research for Health Beyond the microscope, emerging technologies … Continue reading →